SynCore Biotechnology Co Documents
Documents
0
Ticker
4192.TWO
ISIN
TW0004192000
SynCore Biotechnology Co SEC Filings
Type | Report | Date |
|---|---|---|
| No documents available | ||
SynCore Biotechnology Co Documents 2026
This page contains all official documents and SEC filings for SynCore Biotechnology Co stock (4192.TWO, ISIN: TW0004192000). This includes annual reports (Form 10-K), quarterly reports (Form 10-Q), and insider transactions (Form 4). Currently 0 documents are available. Data is updated regularly to provide investors with a complete overview of SynCore Biotechnology Co's regulatory filings.
SynCore Biotechnology Co Stock analysis
SynCore Biotechnology Co SynCore Biotechnology Co Ltd, based in Dongshan, Yilan, Taiwan, operates in the Health Care sector with a focus on Pharmaceuticals. The company develops new drugs and integrates technology, employing 50 full-time staff. Its main product is SB03 Veregen, alongside research and development of anticancer drugs SB01 (injection and oral forms). SynCore primarily distributes its products within Taiwan.